Chunlan Zhuang

机构：Xiamen University, Chinese Academy of Medical Sciences & Peking Union Medical College · ORCID：0000-0002-8253-2515

发表论文 34 篇 · 总被引 737 次 · h-index 12

代表论文

• Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials (2022 · The Lancet Respiratory Medicine · 被引 145)
• A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2 (2022 · 中国科学通报：英文版 · 被引 130)
• Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial (2023 · The Lancet Respiratory Medicine · 被引 74)
• Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial (2024 · The Lancet · 被引 73)
• Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters (2023 · Nature Communications · 被引 58)
• Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial (2023 · Emerging Microbes & Infections · 被引 25)